REGISTERED NUMBER: 10710018 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Springbanks Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

S Umranikar

Mrs A Umranikar

REGISTERED OFFICE:

130 Bournemouth Road

Chandler's Ford

Southampton

Hamphire

SO53 3AL

REGISTERED NUMBER:

10710018 (England and Wales)

ACCOUNTANTS:

CBM Accountants Limited

130 Bournemouth Road

Chandler's Ford

Eastleigh

Hampshire

SO53 3AL

FIXED ASSETS

Tangible assets

4

62,086

40,513

CURRENT ASSETS

Debtors

5

325,356

163,382

Cash at bank and in hand

121,089

236,591

446,445

399,973

CREDITORS

Amounts falling due within one year

6

30,359

32,126

NET CURRENT ASSETS

416,086

367,847

TOTAL ASSETS LESS CURRENT LIABILITIES

478,172

408,360

PROVISIONS FOR LIABILITIES

1,140

928

NET ASSETS

477,032

407,432

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

476,932

407,332

SHAREHOLDERS' FUNDS

477,032

407,432

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 November 2025 and were signed on its behalf by:

S Umranikar - Director

1.	STATUTORY INFORMATION

Springbanks Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

2% on cost

Plant and machinery

-

20% on cost

Fixtures and fittings

-

25% on cost

Computer equipment

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - NIL ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

Plant and

and

Computer

property

machinery

fittings

equipment

Totals

£

£

£

£

£

COST

At 1 April 2024

36,803

917

1,744

11,052

50,516

Additions

20,721

247

732

1,779

23,479

At 31 March 2025

57,524

1,164

2,476

12,831

73,995

DEPRECIATION

At 1 April 2024

-

-

1,744

8,259

10,003

Charge for year

-

270

132

1,504

1,906

At 31 March 2025

-

270

1,876

9,763

11,909

NET BOOK VALUE

At 31 March 2025

57,524

894

600

3,068

62,086

At 31 March 2024

36,803

917

-

2,793

40,513

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

2,670

9,640

Other debtors

322,686

153,742

325,356

163,382

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

25,213

28,098

Other creditors

5,146

4,028

30,359

32,126

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

90

Ordinary "A" shares

£1

90

90

10

Ordinary "B" Shares

£1

10

10

100

100